Verition Fund Management’s Epizyme, Inc EPZM Stock Holding History

Verition Fund Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,984	Closed	-$34K	–	3337
2022 Q2	$34K	Buy	+22,984	New	+$16.9K	﹤0.01%	2184

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Verition Fund Management's EPZM Position: Q3 2022 in Review

Verition Fund Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 22,984 shares — an estimated $34K sold.

Verition Fund Management first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $34K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Verition Fund Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Verition Fund Management sold 22,984 Epizyme, Inc shares in Q3 2022, an estimated $34K.
Verition Fund Management first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Verition Fund Management's Epizyme, Inc position peaked at $34K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Verition Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.